ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

ADXN Addex Therapeutics Ltd

8,60
-0,04 (-0,46%)
31 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Addex Therapeutics Ltd ADXN NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,04 -0,46% 8,60 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
8,93 8,39 8,93 8,60 8,64
mais cotações »

Notícias Recentes

Data Hora Fonte Título
31/05/202402:00GLOBEAddex Therapeutics to Release Q1 2024 Financial Results and..
08/05/202402:00GLOBEAddex to Present at Bio€quity Europe 2024
29/04/202402:00GLOBEAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
19/04/202402:00GLOBEAddex to Present at the Swiss Biotech Day 2024
18/04/202402:00GLOBEAddex Therapeutics Reports Full Year 2023 Financial Results..
11/04/202402:00GLOBEAddex Therapeutics to Release Full-Year 2023 Financial..
03/04/202402:00GLOBEAddex and Perceptive Launch Neurosterix with $63 Million to..
14/03/202403:00GLOBEAddex to Present at the Bio-Europe Spring 2024 Conference
31/01/202403:00GLOBEAddex Enters into At-The-Market ADS Offering Agreement with..
09/01/202403:00GLOBEAddex to Present at the Swiss Equities Baader Conference
05/01/202403:30GLOBEAddex to Present at Biotech Showcase™ 2024
20/12/202303:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
14/12/202303:00GLOBEAddex Creates Treasury Shares
29/11/202303:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
28/11/202303:00GLOBEAddex Convenes Extraordinary General Meeting
23/11/202303:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
14/11/202303:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
08/11/202303:00GLOBEAddex Regains Nasdaq Listing Compliance
02/11/202303:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
20/10/202302:00GLOBEAddex Completes ADS Ratio Change
06/10/202317:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
20/09/202302:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
06/09/202302:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
05/09/202302:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
04/09/202302:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
10/08/202302:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
04/08/202302:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
03/08/202302:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
24/07/202302:00GLOBEAddex mGlu2PAM Demonstrates Potential in Substance Use..
15/06/202302:00GLOBEAddex Increases Issued Share Capital to Create Treasury..

Seu Histórico Recente